Tag: variation filings

Regulatory Notifications & Filings: End-to-End Framework for GxP-Regulated Environments Regulatory Notifications & Filings: End-to-End Framework for GxP-Regulated Environments Understanding Regulatory Notifications and Filings in GxP Environments In the context of Good Practice (GxP) regulations, understanding the framework for regulatory notifications and filings is critical for clinical trial services. GxP encompasses a range of regulations and…

Read More “Regulatory Notifications & Filings: End-to-End Framework for GxP-Regulated Environments” »

How to Design Regulatory Notifications & Filings That Survives FDA, EMA and MHRA Inspections Designing regulatory notifications and filings in the clinical research domain is a multidimensional process entailing precise adherence to Good Clinical Practice (GCP) guidelines and ensuring compliance with regulatory bodies such as the FDA, EMA, and MHRA. This comprehensive guide offers a…

Read More “How to Design Regulatory Notifications & Filings That Survives FDA, EMA and MHRA Inspections” »

Regulatory Notifications & Filings in Practice: Step-by-Step Guide for QA and Clinical Teams Regulatory Notifications & Filings in Practice: Step-by-Step Guide for QA and Clinical Teams In the realm of clinical trials, regulatory notifications and filings are critical processes that ensure compliance with Good Clinical Practice (GCP), regulatory standards, and the integrity of clinical research…

Read More “Regulatory Notifications & Filings in Practice: Step-by-Step Guide for QA and Clinical Teams” »

Common Pitfalls in Regulatory Notifications & Filings—and How to Avoid Compliance Findings Common Pitfalls in Regulatory Notifications & Filings—and How to Avoid Compliance Findings Regulatory notifications and filings are critical components of clinical trials, ensuring that sponsors and investigators remain compliant with Good Clinical Practice (GCP) and regulatory requirements. In this guide, we will explore…

Read More “Common Pitfalls in Regulatory Notifications & Filings—and How to Avoid Compliance Findings” »

Aligning Regulatory Notifications & Filings With Risk Management, CAPA and QMS Requirements In the highly regulated environment of clinical trials, especially precision medicine clinical trials, alignment of regulatory notifications and filings with Quality Management System (QMS) requirements, Corrective and Preventive Actions (CAPA), and overall risk management is paramount. This tutorial provides a comprehensive, step-by-step guide…

Read More “Aligning Regulatory Notifications & Filings With Risk Management, CAPA and QMS Requirements” »